Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 25, 2026 , agilon health, inc. (the “Company”), a Delaware corporation, issued a press release settin
Regulation FD Disclosure. On February 25, 2026 , the Company issued an investor presentation regarding the Company’s financial results for the three and twelve
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated February 25, 2026. 99.2 Investor Presentation dated February